'Pompe disease' diaporamas de présentation

New Jersey Institute of Technology

1.3k views • 94 slides

New Ideas and Dilemmas from Recent Clinical Research in Muscle Diseases

New Ideas and Dilemmas from Recent Clinical Research in Muscle Diseases. Richard J. Barohn, M.D. Gertrude and Dewey Ziegler Professor of Neurology Chair, Department of Neurology University of Kansas Medical Center Kansas City, Kansas KUMC Neurology/Neurosurgery Grand Rounds December 21, 2012.

612 views • 48 slides

Glycogen Storage Disease

Glycogen Storage Disease. Presented by: Colleen Poling. What is Glycogen Storage Disease?. Type I Glycogen Storage Disease- Type I GSD. AKA: von Gierkes disease, Type I Glycogenosis, Hepatorenal Glycogenosis . Therapy/Treatments for Type I GSD. Type II Glycogen Storage Disease Type II GSD.

5.93k views • 28 slides

Overview of the NewSTEPs New Disorders Implementation Project

Overview of the NewSTEPs New Disorders Implementation Project. Kshea Hale, MPH Sr. Specialist, Newborn Screening and Genetics

275 views • 27 slides

1 st Annual New England Pompe Family Support Group Meeting

588 views • 10 slides

Pompe Disease Market

Pompe Disease market outlook helps in building the detailed comprehension of the historical, current and forecasted trend of the market by evaluating the impact of present therapies on the market, unmet needs, drivers and barriers and need of better technology. The expected launch of emerging therapies such as AT-GAA (Amicus Therapeutics), is assumed to create an affirmative impact on the Pompe Disease market in the upcoming years.

138 views • 10 slides

Global Pompe Disease Market 2015 - Size, Share, Growth & Forecast 2019

292 views • 7 slides

Pompe Disease Therapeutic Pipeline Review, H1 2015

226 views • 6 slides

Dubai International Pharmaceutical & Technology Conference & Exhibition

https://duphat.ae/pompe-disease-rare-but-still-matters/t Pompe Disease u2013 Rare but still Matters Pompe Diseases are usually characterized by a deficiency of an enzyme called acid alfa glucosidase (GAA). The enzyme helps by breaking down complex sugars in the body which, when in deficiency causes Pompe disease.

37 views • 3 slides

Supplemental Fi gure 1.

Supplemental Fi gure 1. Box-whiskers plot of Glc 4 concentration in urine samples of controls and patients with Pompe disease as a function of age.

108 views • 1 slides